JOUNCE THERAPEUTICS, INC.

Profile

Company Names

JOUNCE THERAPEUTICS, INC.

Addresses

780 MEMORIAL DRIVE, CAMBRIDGE, MA 02139

1030 MASSACHUSETTS AVE., CAMBRIDGE, MA 02138

Phone Numbers

857-259-3840

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$90,999,995.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-10-16 
$34,999,995.00 
$34,999,995.00 
$0.00 
Equity 
1
2015-04-17 
$56,000,000.00 
$56,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANNA 
L. 
BARRY 
EXECUTIVE OFFICER
JOUNCE THERAPEUTICS, INC.
HUGH 
M. 
COLE 
EXECUTIVE OFFICER
JOUNCE THERAPEUTICS, INC.
LUIS A. 
 
DIAZ, JR. 
DIRECTOR
JOUNCE THERAPEUTICS, INC.
KIM 
C. 
DRAPKIN 
EXECUTIVE OFFICER
ELEVEN BIOTHERAPEUTICS, INC.   |  JOUNCE THERAPEUTICS, INC.   |  YUMANITY THERAPEUTICS, INC.
KIMBERLEE 
C. 
DRAPKIN 
EXECUTIVE OFFICER
JOUNCE THERAPEUTICS, INC.   |  KINETA, INC./DE
BARBARA 
 
DUNCAN 
DIRECTOR
EDGEMONT PHARMACEUTICALS, LLC   |  INTERCEPT PHARMACEUTICALS INC   |  MEDGENICS, INC.   |  AEVI GENOMIC MEDICINE, INC.   |  JOUNCE THERAPEUTICS, INC.
DUNCAN 
 
HIGGONS 
DIRECTOR
AGIOS PHARMACEUTICALS INC   |  JOUNCE THERAPEUTICS, INC.
ROBERT 
 
IANNONE 
DIRECTOR
JOUNCE THERAPEUTICS, INC.   |  AUTOLUS THERAPEUTICS PLC
ROBERT 
 
KAMEN 
DIRECTOR
BIOASSETS DEVELOPMENT CORP   |  ANCHORTHERAPEUTICS, INC   |  LYCERA CORP   |  JOUNCE THERAPEUTICS, INC.   |  NEON THERAPEUTICS, INC.
PERRY 
 
KARSEN 
DIRECTOR
AGIOS PHARMACEUTICALS INC   |  ALLIQUA, INC.   |  E-SCAPE BIO, INC.   |  ESCAPE BIO, INC.   |  JOUNCE THERAPEUTICS, INC.   |  GRAPHITE BIO, INC.
RICHARD 
 
MURRAY 
EXECUTIVE OFFICER, DIRECTOR
VARIANCE ACRYLIC FINISHES, LLC   |  JOUNCE THERAPEUTICS, INC.   |  PLATELET BIOGENESIS, INC.   |  TELARUS PARENT HOLDINGS, INC.   |  BWO CORP.   |  DUALITAS THERAPEUTICS, INC.
CARY 
 
PFEFFER 
DIRECTOR
ELEVEN BIOTHERAPEUTICS, INC.   |  TARIS BIOMEDICAL INC   |  EDIMER PHARMACEUTICALS, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  RHEOS MEDICINES, INC.   |  THIRD ROCK VENTURES V, L.P.   |  JOUNCE THERAPEUTICS, INC.   |  FAZE MEDICINES, INC.   |  THIRD ROCK VENTURES VI, L.P.
CARY 
G. 
PFEFFER 
DIRECTOR
ELEVEN BIOTHERAPEUTICS, INC.   |  JOUNCE THERAPEUTICS, INC.   |  MANAT BIO, INC.
ROBERT 
 
TEPPER 
DIRECTOR
CERULEAN PHARMA INC.   |  ALNARA PHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  FOUNDATION MEDICINE, INC.   |  KALA PHARMACEUTICALS, INC.   |  BLUEBIRD BIO, INC.   |  THIRD ROCK VENTURES III, L.P.   |  ALLENA PHARMACEUTICALS, INC.   |  JOUNCE THERAPEUTICS, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  NEON THERAPEUTICS, INC.   |  THIRD ROCK VENTURES V, L.P.   |  FAZE MEDICINES, INC.   |  THIRD ROCK VENTURES VI, L.P.
ELIZABETH 
G. 
TREHU 
EXECUTIVE OFFICER
CONSTELLATION PHARMACEUTICALS INC   |  JOUNCE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-10-29
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-10-16 
2015-04-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#